Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1Phase 1 1

Status

Recruiting 2Active not recruiting 1

Sponsor Class

OTHER 3NIH 2

Study Type

Interventional 3

Sponsor

Cancer Type

Head & Neck 3Endocrine 1

Conditions

Thyroid Neoplasms 2Differentiated Thyroid Carcinoma 1

Interventions

Magnetic Resonance Spectroscopy 287Specimen Handling 285pembrolizumab 258Cyclophosphamide 237Radiotherapy 233Nivolumab 187Cisplatin 174Biopsy 170Carboplatin 155Radiosurgery 142fludarabine 131Blood Specimen Collection 130Surveys and Questionnaires 120Gemcitabine 120Paclitaxel 115venetoclax 114Standard of Care 112Dexamethasone 105Bevacizumab 98Radiation 97Rituximab 92Oxaliplatin 89Cytarabine 88Capecitabine 88Drug Therapy 86Ipilimumab 85Doxorubicin 83durvalumab 81atezolizumab 76fludarabine phosphate 73

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Iodine-124 × 90 days × Clear all
NCT01704586 2026-05-12

CLERAD-PROBE

University of Wuerzburg

Phase NA Active not recruiting
340 enrolled
EndocrineHead & Neck

Differentiated Thyroid Carcinoma

NCT06961084 2026-04-22

Comparison of I-124 PET/CT for the Diagnosis of Thyroid Cancer

University of California, San Francisco

Phase 2 Recruiting
62 enrolled
Head & Neck

Thyroid Neoplasms

NCT03647358 2026-04-14

Lesion Dosimetry With Iodine-124 in Metastatic Thyroid Carcinoma

Memorial Sloan Kettering Cancer Center

Phase 1 Recruiting
60 enrolled
Head & Neck

Thyroid Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡